C18.4

Clinical Causes: Genetic mutations that lead to abnormal cell growth Family history of colorectal cancer Chronic inflammatory diseases of the colon, such as ulcerative colitis or Crohn's disease Lifestyle factors including a diet high in red or processed meats and low in fiber Sedentary lifestyle and lack of physical activity Obesity and excess body weight Smoking and heavy alcohol consumption Age, particularly over 50 years old

Key Symptoms: Altered bowel habits, such as diarrhea or constipation Persistent abdominal discomfort or cramps Blood in stool or rectal bleeding Unexplained weight loss Fatigue and weakness A feeling of incomplete bowel emptying Narrowing of stool or a change in stool caliber

Diagnosis Path: Diagnosing malignant neoplasm of the transverse colon usually involves a combination of methods, including: - **Colonoscopy**: A procedure that uses a flexible camera to visualize the interior of the colon and allows for biopsy - **Biopsy**: Tissue samples taken during colonoscopy are examined under a microscope for cancer cells - **Imaging tests**: Such as CT scans, MRI, or ultrasound to assess the extent of cancer spread - **Blood tests**: Including carcinoembryonic antigen (CEA) levels, which may be elevated in colon cancer - **Staging assessments**: To determine the progression and spread of the cancer, essential for planning treatment

Treatment Protocols: Treatment options for malignant neoplasm of the transverse colon typically involve a multidisciplinary approach: - **Surgical removal**: The primary treatment often involves resecting the tumor along with surrounding healthy tissue and lymph nodes - **Chemotherapy**: May be recommended to kill remaining cancer cells post-surgery or to shrink tumors before surgery - **Radiation therapy**: Less common but may be used in specific cases to target the tumor - **Targeted therapy**: Utilizing drugs that interfere with cancer growth mechanisms - **Follow-up care**: Regular check-ups and testing to monitor for recurrence The specific treatment plan depends on the stage of the cancer, overall health, and patient preferences.